<DOC>
	<DOCNO>NCT01454687</DOCNO>
	<brief_summary>The term epidermolysis bullosa ( EB ) use describe group genetic skin disease associate skin weakness , blister , chronic wound . `` Revertant mosaicism '' mean two genetically different population cell due spontaneous mutation . Some EB patient normal , non-fragile skin patch may area revertant mosaicism . In revertant area , proteins function normally , like non-EB skin . In study , plan culture cell revertant area graft wound area .</brief_summary>
	<brief_title>Grafting Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous Keratinocytes</brief_title>
	<detailed_description />
	<mesh_term>Epidermolysis Bullosa</mesh_term>
	<criteria>Clinical diagnosis EB ( simplex , junctional dystrophic ) Areas revertant skin confirm biopsy 18 year old subject willing able give consent Confirmation EB diagnosis immunofluorescence ( IF ) , electron microscopy ( EM ) , genetic test confirm mutation At least 100 200 cm2 open erosion trunk and/or extremity suitable skin graft Able undergo adequate anesthesia allow graft procedure take place Medical instability limit ability travel Stanford University Medical Center The presence medical illness expect complicate participation and/or compromise safety technique Active infection HIV , hepatitis B , hepatitis C Active infection area undergo graft Evidence systemic infection Current evidence history skin cancer area undergo graft Active drug alcohol addiction Hypersensitivity vancomycin amikacin Receipt chemical biological study product specific treatment ofEB past six month Positive pregnancy test breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>